Drug
Abx464
Abx464: highest development phase Phase 2, developed by Orion Corporation. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Orion Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| ABX464 NCT03368118 | Phase 2 | Ulcerative Colitis |
Latest
No recent events.
Follow Abx464 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.